Ionis Pharmaceuticals Inc Insider Selling: Eric Swayze Trims Stake

A Form 4 filed with the SEC shows Eric Swayze, EVP Research at Ionis Pharmaceuticals Inc (IONS), sold 53 shares of company stock on 2026-10-16.

The transaction was executed at a price of $43.54 per share, for a total value of approximately $2,308.

Under SEC rules, corporate insiders — officers, directors, and holders of more than 10% of a company's shares — are required to report changes in their ownership within two business days of the transaction via Form 4.

Sales by insiders often reflect routine portfolio management or pre-scheduled trading plans rather than a view on the company's prospects.